PALISADE BIO, INC. (PALI) Shareholders’ equity 2016–2025
PALISADE BIO, INC. (PALI) shareholders’ equity at each fiscal year-end, per SEC filings.
$129.4MFY2025 · since FY2016: $11.3M → $129.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $129.4M | +1626.9% |
| FY2024 | $7.5M | -33.8% |
| FY2023 | $11.3M | -9.3% |
| FY2022 | $12.5M | — |
| FY2020 | -$16.6M | -99.3% |
| FY2019 | -$8.3M | -237.7% |
| FY2018 | $6.0M | -29.0% |
| FY2017 | $8.5M | -24.8% |
| FY2016 | $11.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice